Parhelia Biosciences | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Paradromics Inc.
United States
- Austin, Texas
- 19/05/2023
- Unknown
- $33,000,000
The brain is a data organ; it needs a data interface. At Paradromics, we’re building a direct data interface with the brain to unlock technology solutions to unmet medical challenges. A revolutionary leap beyond today’s lab-confined brain-computer interfaces (BCI), our Connexus® Direct Data Interface (DDI) collects an unprecedented number of individual neural signals with a fully-implantable device designed for long-term daily service. Our first clinical application is an assistive communication device for patients who’ve lost the physical ability to speak or type. The Connexus DDI platform has boundless potential for future applications, from enabling people with sensory and motor impairment to treating neuropsychiatric disorders.
Paradromics was founded in 2015 by a team of engineers and neuroscientists, received early support from both NIH and DARPA, and is currently backed by venture capital.
- Industry Biotechnology Research
- Website https://www.paradromics.com/
- LinkedIn https://www.linkedin.com/company/paradromics-inc/
Related People
Matt AngleFounder
United States -
Austin, Texas
Together with my colleagues and collaborators, I aim to develop a new generation of neural interfaces that will be used in basic research and clinical applications.
Prove | $40,000,000 | (Oct 18, 2023)
Reality Defender | $15,000,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Nucleus RadioPharma | $56,000,000 | (Oct 18, 2023)
Society Brands | $25,000,000 | (Oct 18, 2023)
Nova Credit | $45,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
Zelus Analytics | Undisclosed Amount | (Oct 18, 2023)
Scorability | $11,000,000 | (Oct 18, 2023)